Search Results | Diabetes Care | American Diabetes Association

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

Stine Elkjaer Nielsen, MD, Takeshi Sugaya, MD, PHD, Peter Hovind, MD, DMSC, Tsuneharu Baba, MD, PHD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC

Diabetes Care 2010;33(6):1320–1324

DOI: https://doi.org/10.2337/dc09-2242

Published: 25 February 2010

View article

Journal Articles

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition

Stine E. Nielsen, MD, Takeshi Sugaya, MD, PHD, Lise Tarnow, MD, DMSC, Maria Lajer, CANDSCI, Katrine J. Schjoedt, MD, Anne Sofie Astrup, MD, Tsuneharu Baba, MD, PHD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC

Diabetes Care 2009;32(9):1684–1688

DOI: https://doi.org/10.2337/dc09-0429

Published: 05 June 2009

View article

Journal Articles

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Anders Jorsal, Noelynn Oliver, PHD, Peggy Roestenberg, PHD, Yasuhiko Ito, MD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC, Frans A. van Nieuwenhoven, PHD, Roel Goldschmeding, MD, PHD

Diabetes Care 2008;31(6):1177–1182

DOI: https://doi.org/10.2337/dc07-2469

Published: 01 June 2008

View article

Journal Articles

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes: Response to Farvid et al.

Peter Rossing, MD, DMSC, Mark E. Cooper, MD, PHD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2006;29(3):747–748

DOI: https://doi.org/10.2337/diacare.29.03.06.dc05-2144

Published: 01 March 2006

View article

Journal Articles

Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Steen Andersen, MD, DMSC, Peter Hovind, MD, DMSC, Hans-Henrik Parving, MD, DMSC, Roel Goldschmeding, MD, PHD, Frans A. van Nieuwenhoven, PHD

Diabetes Care 2006;29(1):83–88

DOI: https://doi.org/10.2337/diacare.29.01.06.dc05-1670

Published: 01 January 2006

View article

Journal Articles

Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy : A randomized, double-masked, cross-over study

Kasper Rossing, MD, Katrine J. Schjoedt, MD, Ulla M. Smidt, Frans Boomsma, PHD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2005;28(9):2106–2112

DOI: https://doi.org/10.2337/diacare.28.9.2106

Published: 01 September 2005

View article

Journal Articles

Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy

Sofia B. Ahmed, MD, MMSC, Peter Hovind, MD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, Deborah A. Price, MD, Lori M. Laffel, MD, MPH, M. Cecilia Lansang, MD, MPH, Radomir Stevanovic, MD, Naomi D.L. Fisher, MD, Norman K. Hollenberg, MD, PHD

Diabetes Care 2005;28(8):1988–1994

DOI: https://doi.org/10.2337/diacare.28.8.1988

Published: 01 August 2005

View article

Journal Articles

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria: Response to Kaiser, Florack, and Sawicki

Steen Andersen, MD, Jens Bröchner-Mortensen, MD, DMSC, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2004;27(6):1521–1522

DOI: https://doi.org/10.2337/diacare.27.6.1521-a

Published: 01 June 2004

View article

Journal Articles

Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes

Lise Tarnow, MD, DMSC, Peter Hovind, MD, Tom Teerlink, PHD, Coen D.A. Stehouwer, MD, PHD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2004;27(3):765–769

DOI: https://doi.org/10.2337/diacare.27.3.765

Published: 01 March 2004

View article

Journal Articles

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria

Steen Andersen, MD, Jens Bröchner-Mortensen, MD, DMSC, Hans-Henrik Parving, MD, DMSC, Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria Study Group

Diabetes Care 2003;26(12):3296–3302

DOI: https://doi.org/10.2337/diacare.26.12.3296

Published: 01 December 2003

View article

Journal Articles

ACE Insertion/Deletion Genotypes and Angiotensin II Receptor Blockade in Diabetic Nephropathy: Is there a light at the end of the tunnel?

Steen Andersen, MD, Peter Jacobsen, MD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2003;26(10):2962–2963

DOI: https://doi.org/10.2337/diacare.26.10.2962-a

Published: 01 October 2003

View article

Journal Articles

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?

Steen Andersen, MD, Lise Tarnow, MD, DMSC, Francois Cambien, MD, Peter Rossing, MD, DMSC, Tina R. Juhl, Jaap Deinum, MD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2003;26(5):1501–1506

DOI: https://doi.org/10.2337/diacare.26.5.1501

Published: 01 May 2003

View article

Journal Articles

Autoregulation of Glomerular Filtration Rate in Patients With Type 2 Diabetes During Isradipine Therapy

Per K. Christensen, MD, Kamran Akram, MD, Karen B. Kønig, MD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2003;26(1):156–162

DOI: https://doi.org/10.2337/diacare.26.1.156

Published: 01 January 2003

View article

Journal Articles

Remission of Nephrotic-Range Albuminuria in Type 1 Diabetic Patients

Peter Hovind, MD, Peter Rossing, MD, DMSC, Lise Tarnow, MD, Henrik Toft, Jeppe Parving, Hans-Henrik Parving, MD, DMSC

Diabetes Care 2001;24(11):1972–1977

DOI: https://doi.org/10.2337/diacare.24.11.1972

Published: 01 November 2001

View article

Journal Articles

Increased Left Ventricular Mass in Normotensive Type 1 Diabetic Patients With Diabetic Nephropathy

Asako Sato, MD, Lise Tarnow, MD, Hans-Henrik Parving, MD, DMSC

Diabetes Care 1998;21(9):1534–1539

DOI: https://doi.org/10.2337/diacare.21.9.1534

Published: 01 September 1998

View article

Journal Articles

Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients

Flemming S Nielsen, MD, Asako Sato, MD, Samir Ali, MD, Lise Tarnow, MD, Ulla M Smidt, Jens Kastrup, MD, DMSC, Hans-Henrik Parving, MD, DMSC

Diabetes Care 1998;21(5):804–809

DOI: https://doi.org/10.2337/diacare.21.5.804

Published: 01 May 1998

View article

Journal Articles

White Coat Hypertension in NIDDM Patients With and Without Incipient and Overt Diabetic Nephropathy

Flemming S Nielsen, MD, Pernille Gæde, MD, Pernille Vedel, MD, Oluf Pedersen, MD, DMSC, Hans-Henrik Parving, MD, DMSC

Diabetes Care 1997;20(5):859–863

DOI: https://doi.org/10.2337/diacare.20.5.859

Published: 01 May 1997

View article

Journal Articles

Raised Serum Sialic Acid Concentration in NIDDM Patients With and Without Diabetic Nephropathy

Jian-Wen Chen, MD, Mari-Anne Gall, MD, Hiroki Yokoyama, MD, Jan S Jensen, MD, Marja Deckert, Hans-Henrik Parving, MD, DMSC

Diabetes Care 1996;19(2):130–134

DOI: https://doi.org/10.2337/diacare.19.2.130

Published: 01 February 1996

View article

NARROW

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes: Response to Farvid et al.

Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy

Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy : A randomized, double-masked, cross-over study

Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria: Response to Kaiser, Florack, and Sawicki

Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes

Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria

ACE Insertion/Deletion Genotypes and Angiotensin II Receptor Blockade in Diabetic Nephropathy: Is there a light at the end of the tunnel?

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?

Autoregulation of Glomerular Filtration Rate in Patients With Type 2 Diabetes During Isradipine Therapy

Remission of Nephrotic-Range Albuminuria in Type 1 Diabetic Patients

Increased Left Ventricular Mass in Normotensive Type 1 Diabetic Patients With Diabetic Nephropathy

Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients

White Coat Hypertension in NIDDM Patients With and Without Incipient and Overt Diabetic Nephropathy

Raised Serum Sialic Acid Concentration in NIDDM Patients With and Without Diabetic Nephropathy

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only